We are happy to share a new scientific publication that highlights the potential of using the Phelix phage test in addressing the challenges for diagnosis of borrelia-related infections. Given that tick-borne diseases pose a growing global concern, accurate diagnosis is crucial. Traditional diagnostic tests can be problematic due to the complex immune evasion strategies of Borrelia species. The use of bacteriophages as diagnostic tools is able to overcome these challenges, due to their high specificity and potential for greater sensitivity. The Phelix phage test specifically targets borrelia-specific bacteriophages in biological samples (blood, urine, ticks, etc), which could significantly enhance patient outcomes and public health. Read article HERE
Overcoming the Challenges of Lyme Disease Diagnosis: The Role of Phage-based Testing
- R.E.D. Laboratories
Most recent posts
TRENDING DEZE MAAND
La 4ᵉ Conférence Européenne sur la Maladie de Lyme et les Crypto-Infections aura lieu du vendredi 4…
ontdek meer
Red Labs shares insight on how Folate Receptor Antibodies impacts on Autism , the possible treatme…
ontdek meer
Borrelia miyamotoi, a tick-borne bacterium, is gaining recognition as an emerging global pathogen, …
ontdek meer